Professional Documents
Culture Documents
Duke Surgery 2018-2019 Resident's Guide
Duke Surgery 2018-2019 Resident's Guide
RESIDENT
CANDIDATE’S
GUIDE
2018 – 2019
Contents
Table of Contents
WELCOME
Message from the Chair 5
Message from Residency Program Director 6
RESIDENTS
Residents’ Lounge 41
Positions of Chief Residents of Surgery 42
Chief Resident Profiles 78
Current Residents 89
Dedicated Resident Research Program in General Surgery 106
RESEARCH LABORATORIES
Duke Endocrine Neoplasia Diseases Research Group 108
Determinants of Progression in Early Breast and Ovarian Cancer 108
2
Contents
FACULTY 121
Abdominal Transplant Surgery 122
Metabolic and Weight Loss Surgery 125
Pediatric General Surgery 127
Plastic, Maxillofacial, and Oral Surgery 128
Surgical Oncology 133
Surgical Sciences 142
Trauma and Critical Care Surgery 150
Vascular and Endovascular Surgery 153
Cardiovascular and Thoracic Surgery 157
3
Stay Connected.
Click. Like. Follow. Watch.
4
Welcome
I genuinely look forward to meeting each of you, learning what contribution you hope to make to
the field of surgery, and determining how I can help you reach your career goals.
Sincerely,
Surgeon-in-Chief
Duke University Health System
5
Welcome
The cornerstone of the General Surgery Residency at Duke is the two-year research fellowship,
typically integrated between the second and third clinical years. During these two years, our
surgical residents begin a dedicated investigative experience designed to give each resident an
opportunity to develop granular expertise in an area of their choosing. These can include basic
or translational science projects, experiences in health services or clinical outcomes research,
studies in global medicine, or indeed any thoughtfully conceived knowledge creation endeavor.
Innumerable basic science opportunities exist not only in the Department of Surgery, but also
across both the graduate and undergraduate campuses.
There are also multiple dual-degree opportunities obtained via the Duke Clinical Research
Training Program, the Fuqua School of Business, and the Duke Clinical Research Institute. The
goal of this research experience is to create thought leaders in academic surgery at both an
6
Welcome
institutional and national level, and to provide each Duke resident with a concentrated expertise in
their chosen field.
You should consider a number of factors when choosing a residency program and clearly one of the
most important is the track record of the recent graduates. The training program is intentionally
broad-based and has produced graduates with a wide variety of clinical and research interests. As
you will find in the summaries enclosed, our graduates obtain access to the most highly sought-
after academic jobs and specialty training fellowship programs, and make up a significant number
of the chairs, chiefs, and program directors nationwide.
We are proud of our program and achievements, and we are honored that accomplished medical
students like you have expressed interested in our residency. I hope that over the course of your
interview experience you come away as excited as I am about our programs.
Sincerely yours,
John Migaly, MD
Program Director
General Surgery Residency
7
About the
Department
of Surgery
As one of the top surgery programs in the world, the Duke Department of Surgery is dedicated
to providing unparalleled clinical care, conducting pioneering research, and training the next
generation of leaders in clinical and academic surgery. Patients from all over the world seek
treatment from its team of experts, who have access to the clinical standard in all surgical
domains, as well as experimental procedures and specialized care that extends beyond the
current offerings of most hospitals. This provides the best opportunity for each patient to
gain their best clinical outcome, and as such attracts a patient population representing an
exceptionally broad clinical spectrum from which the trainee can learn.
Since the 1930s, Duke Surgery has led the way in medical innovations. It established the nation’s
first brain tumor program in 1937 and was one of the first U.S. institutions to successfully
perform a kidney transplant nearly 30 years later. Duke surgeons have pioneered techniques
in vascular free flaps and cardiopulmonary bypass, and led innovations in sterile technique,
advanced immunotherapy, advanced oncologic viral therapy, and vaccine-based immunotherapy
for cancer. In 2013, surgeons implanted a bioengineered vascular graft in a patient — a first-of-
its-kind operation in the United States with potential to revolutionize vascular surgery.
The Department currently provides attending surgical coverage at Duke University Hospital, Duke
Regional Hospital, Duke Raleigh Hospital, and two VA hospitals: Asheville VA and Durham VA
hospitals. The general surgery faculty maintains an exceptionally busy practice, conducting over
30,000 operative procedures per year on a background of 70,000 procedures across all surgical
specialities. As the Triangle area is perennially one of the fastest growing communities in the
United States, Duke continues to expand with new operative platforms and a growing clinical
and research faculty. This robust clinical volume combined with remarkably competitive faculty
members adept in acquiring grant funding has led to a fiscally solvent department. It is this
solvency that allows the Department to continue its unwavering dedication to residency training
both on the wards and in the laboratory.
8
About the
Department
of Surgery
Duke Hospital in
the Snow (DUMC
Archives)
1891
Trinity College President John Franklin Crowell makes public a plan for starting a medical college
with a teaching hospital at Trinity College.
1924
James B. Duke establishes The Duke Endowment and allocates part of his $40 million gift to
transform Durham’s Trinity College into Duke University.
1925
James B. Duke makes an additional bequest to establish the Duke School of Medicine, Duke
School of Nursing, and Duke Hospital, with the goal of improving health care in the Carolinas and
nationwide.
1927
Construction begins on the medical school and Duke Hospital.
1929
Three thousand applicants apply to the new medical school. Seventy first- and third-year students
are selected, including four women.
9
About the
Department
of Surgery
1930
Duke Hospital opens July 20, 1930, attracting 25,000 visitors.
Classes begin in hospital administration, dietetics, and medical technology on August 15.
1931
The Duke School of Nursing’s first class of 24 undergraduate students begin classes on January 2.
The dedication ceremony for Duke Medical School and Duke Hospital is held on April 20.
The Private Diagnostic Clinic, Duke’s physician practice organization, is organized September 15.
1940
The first wing is added to Duke Hospital.
The 65th General Hospital is authorized as an affiliated unit of the Duke University School of
Medicine on October 17.
1957
The Outpatient Clinic and Private Diagnostic Clinic as well as the Hanes and Reed private floors
and operating rooms are opened.
The original medical school and hospital are renamed Duke University Medical Center.
Duke Hospital
Main Entrance,
Circa 1940
(DUMC Archives)
10
About the
Department
of Surgery
1966
A new hospital entrance, the Woodhall Building, opens.
1980
The new $94.5 million, 616-bed Duke Hospital opens, bringing the total number of patient beds to
more than 1,000.
1998
The Duke University Health System (DUHS)—an integrated academic health care system serving a
broad area of central North Carolina—is officially created as Duke establishes partnerships with
Duke Regional Hospital, Raleigh Community Hospital, and other regional health care providers.
DUHS today includes three hospitals, ambulatory care and surgery clinics, primary care medical
practice clinics, home health services, hospice services, physician practice affiliations, managed
care providers, and other related facilities and services.
2007
Future DUHS expansion includes the development of the Hospital Addition for Surgery (HAFS)
building.
The Emergency Department (ED) Expansion project provides 71 treatment spaces accommodating
over 60,000 annual visits, including a full Pediatric ED, 4 trauma resuscitation rooms, CT scanner,
X-ray, decontamination area, ambulance garage, a daylit waiting area, and a linear exam area
arrangement for increased efficiency.
2009
DUHS moves forward with the construction of a dedicated, state-of-the-art cancer center and
the new Duke Medicine Pavilion, a major expansion of surgery and critical care services at Duke
University Hospital.
11
About the
Department
of Surgery
2012
A new landmark opens its doors on Duke’s medical center campus—the seven-story,
267,000-square-foot Duke Cancer Center. More than just a modern space, it’s an environment
designed to transform the experience of every patient welcomed inside. The center consolidates
outpatient cancer services and clinical research from across the campus into a patient-centered,
multidisciplinary facility. The building adjoins the current Morris Cancer Clinic and is equipped
with, among other features, 140 examination rooms, 75 infusion stations, a pharmacy, and an
outdoor garden terrace where chemotherapy patients can go while receiving their infusions.
2013
The Mary Duke Biddle Trent Semans Center for Health Education opens in January 2013. The
six-floor, 104,000-square foot building houses a meeting hall, a team-based learning auditorium,
teaching labs, and clinical skills and medical simulation space, including the Surgical Education
and Activities Lab (SEAL).
Mary Duke
Briddle Trent
Semans Center
for Health
Education
12
About the
Department
of Surgery
Duke Medicine
Pavilion at
Duke Universty
Hospital, 2013
The Duke Medicine Pavilion at Duke University Hospital opens in June 2013. The eight-floor,
608,000-square foot pavilion includes 160 critical care rooms, 18 operating rooms, and an imaging
suite. The operating suites feature the latest in surgical technologies, as well as intraoperative
magnetic resonance and computed tomography (CT) imaging capabilities that enable greater
real-time precision and safety in complex procedures. With Duke University Hospital having
to turn more than 900 patients away the previous year due to lack of space, the newly created
critical care beds were urgently needed. Also, the 64 new intermediate care beds allow for optimal
transition of patients from intensive care beds to standard hospital rooms.
The expanded Duke clinical facilities also provide state-of-the-art training and education for the
nearly 900 residents and fellows at Duke—one of the largest training programs in the United
States.
This major expansion project follows several recent significant capital projects throughout Duke
Health, including renovations at Duke Raleigh Hospital and Duke Regional Hospital, and the
opening of several new clinics in Wake County (Brier Creek, Morrisville, Knightdale, and North
Raleigh).
2016
Duke University begins construction of a third Medical Sciences Research Building (MSRB). The
$103 million, 155,000-square-foot building will exclusively house bench lab research.
2017
Duke University Hospital broke ground on a new hosptiral tower due to open in 2020.
13
About the
Department
of Surgery
1936 J. Deryl Hart, MD, introduces ultraviolet lamps into operating rooms to kill
airborne germs that cause postoperative Staph infections, dramatically
reducing the number of infections and related deaths.
1955 Duke initiates children’s amputation clinic for prostheses and management
as part of nationwide network.
1956 Duke becomes the first institution to use systemic hypothermia during
cardiac surgery. This technique of cooling patients to less than 50 degrees
Fahrenheit to minimize tissue damage during lengthy surgical procedures is
now standard practice worldwide.
14
About the
Department
of Surgery
1965 Duke is one of the first institutions in the country to successfully perform a
kidney tranplant.
1969 Duke orthopaedic surgeon performs first total hip replacement in the South.
1971 Duke Comprehensive Cancer Center becomes one of the nation's first cancer
centers.
1972 Duke surgeons are the first to reattach a severed thumb more than eight
hours after it was amputated.
1979 Duke surgeons are the first to treat avascular necrosis (AVN) of the femoral
head with free vascularized fibular graft.
1982 Duke conducts first and only randomized trial comparing radical surgery to
radiation for adenocarcinoma of the prostate gland.
1984 Duke surgeons perform first liver transplant in the state of North Carolina.
1992 Duke physicians perform the first lung transplant and the first heart/lung
transplant in hospital history.
1993 The anti-HIV drug therapy (Fuzeon) is developed by Trimeris as a direct result
of research conducted in the Duke Surgical Oncology Labs.
15
About the
Department
of Surgery
2003 Duke Urology surgeons perform first robotic prostatectomy in the state of
North Carolina.
16
About the
Department
of Surgery
2006 Duke Thoracic Surgery and Duke Urology specialty clinics open in Raleigh, NC.
Duke Weight Loss Surgery Center is designated as a Center of Excellence by
the American Society of Bariatric Surgery.
2007 Duke Otolaryngology - Head and Neck specialty clinic opens in Raleigh, NC.
2008 Duke’s Surgical Education and Activities Lab receives accreditation by the
American College of Surgeons as Comprehensive Education Institute.
2012 Surgical Education and Activities Lab receives first in state robotic trainer.
2013 Duke surgeons begin first ever clinical trial with bioengineered blood vessel.
2014 Duke Heart Transplant team performs the 1000th heart transplant at Duke.
2016 Duke surgeons perform the first hand transplant in North Carolina.
Surgical program at Duke Children’s Hospital receives Level 1 designation
from ACS.
17
About the
Department
of Surgery
Dr. David Sabiston, Jr. conducting teaching rounds with residents under the portrait of Dr. Deryl Hart, founding
Chairman of the Duke Department of Surgery (DUMC Archives)
A Tradition of Excellence
The rich history and high standards that bore Duke University are also deeply rooted within the
Department of Surgery.
18
About the
Department
of Surgery
Dr. David C. Sabiston, Jr. completed medical school and surgical training
at Johns Hopkins Hospital under the mentorship-of Dr. Alfred Blalock.
He distinguished himself in the field of cardiovascular diseases. Notable
among his academic achievements were his pioneering work in the
surgical management of coronary artery disease and, while at Duke,
groundbreaking work in the diagnosis and management of pulmonary
embolism. Dr. Sabiston will be remembered most for his profound
effect on surgical education, both nationally and internationally. This
is most evident when reviewing the list of successful graduates who
have gone on to lead departments, divisions, and programs and whose
David C. Sabiston Jr., MD portraits adorn the hallways outside of the department offices.
1964–1994
19
About the
Department
of Surgery
Dr. Allan D. Kirk was named chair of the Department of Surgery at Duke
University in May 2014. He also was named as the inaugural Surgeon-
in-Chief for the Duke University Health System. Dr. Kirk received his MD
from Duke University School of Medicine in 1987 and completed his
PhD in immunology at Duke in 1992. He completed his general surgery
residency at Duke in 1995, and his multiorgan transplant fellowship
at the University of Wisconsin in 1997. An accomplished scientist and
surgeon, Dr. Kirk is recognized by his peers for his pioneering work in
transplantation and for his outstanding ability to lead. Prior to returning
to Duke, he served as a Commander in the United States Navy at
Allan Kirk, MD, PhD the Naval Medical Research Institute, became the inaugural Chief of
2014–present the Transplantation branch at the National Institutes of Health, and
served as Vice Chair for Research for the Department of Surgery at
Emory University. He has been recognized by induction to the National
Academy of Medcine. His commitment to rigorous education and
training, innovative research, and the most advanced patient care make
him an excellent leader for Duke Surgery.
20
About the
Department
of Surgery
Facilities
The Department of Surgery’s residency program gives students the opportunity to gain hands-on
experience providing care for diverse populations and treating a wide range of conditions. With
five world-class facilities, surgical residents can take advantage of valuable training opportunities,
from pediatric through geriatric procedures, including comprehensive experiences in
hepatobiliary surgery, transplantation, vascular surgery, and advanced laparoscopic procedures.
The program includes experience in community and VA-based care, which is crucial for surgeons
interested in academic careers. Residents become equipped with the knowledge and skills needed
to be competitive in the workforce.
DRH is a 369-bed acute care hospital that has been serving the
community’s health care needs since 1976. A comprehensive
facility, it offers Duke surgical residents experience in inpatient,
outpatient, surgical, and emergency care. The medical facility
also features a level II intensive care nursery, the 30-bed
Durham Regional Rehabilitation Institute, and the Davis
21
About the
Department
of Surgery
Facilities
22
About the
Department
of Surgery
With a top-ranked medical school, health system, and university, Duke University is a hub for
academic excellence and innovation. Located in Durham, N.C. — one of the fastest growing areas
in the country and a center of biomedical research — it produces leaders in fields ranging from
business to engineering to public policy. Duke Health, which comprises Duke University Health
System, Duke University School of Medicine, and Duke University School of Nursing, consistently
ranks as one of U.S. News & World Report’s best medical centers.
Duke Health is an international leader in health care, research, and training. Its state-of-the-art
facilities include the flagship Duke Hospital and two community hospitals, Durham Regional
and Duke Raleigh. It’s also affiliated with other health care facilities, including local hospitals,
community-based primary care physician practices, and hospice care. The School of Medicine has
31 departments, centers, and institutes, and employs more than 2,000 faculty members. Duke
logs more than 61,000 inpatient stays and 1.8 million outpatient visits each year.
Duke Health offers world-class education for some of the brightest minds in medicine. Programs
promote multidisciplinary collaboration between basic science, translational, and clinical faculty.
Trainees are encouraged to pursue research in their area of interest and, upon graduation, are
uniquely positioned for sought-after clinical or research positions.
23
About the
Department
of Surgery
Located halfway between the stunning Blue Ridge Mountains and the spotless beaches of the
Outer Banks, Durham is the fourth largest municipality in North Carolina. Visitors come to
Durham for its sports teams, eclectic restaurants, and diverse culture; residents live here for its
reasonable cost of living, strong sense of community, and agreeable weather. From Forbes to USA
Today, the Raleigh-Durham area consistently lands on the major top 10 lists of best places in the
country to visit, live, and do business.
Durham has the charm of a Southern college town with the amenities of a larger city. The nearby
Research Triangle Park, the largest research park in the country, is a wellspring of advancements
and career opportunities in biotechnology, environmental sciences, and pharmaceuticals. The
annual Full Frame Documentary Film Festival brings together people from all over the world to
showcase the work of new and established filmmakers. With more than 60 parks, an extensive
network of running and biking trails, and several major waterways, the city offers abundant
activities for outdoors enthusiasts. Access to and from Durham is convenient, as the RDU airport
just 12 miles outside the city.
(Clockwise from top left) Eno River State Park. Photo credit: Durham Convention & Visitors Bureau. American
Tobacco Campus. Photo credit: Durham Convention & Visitors Bureau. Durham Bulls Athletic Park. Photo Credit:
Brian Fleming Photography.
24
About the
Department
of Surgery
Community Engagement
ASSET Program
The Department of Surgery has partnered with the Durham Nativity School to provide surgical
skills workshops as part of the Academic Success Through Surgical Education and Training (ASSET)
program. This program aims to foster high achievement in science through surgical education for
financially disadvantaged students at the school.
25
Departmental
Infrastructure for
Clinical Research
Duke SCORES (Surgical Center for Outcomes Research) is a novel, transdisciplinary effort that
promotes excellence in HSR for various surgical patient populations. Duke SCORES serves as a
hub for education, research, mentorship, and resources to enable trainees and faculty to ask and
answer questions with direct translational relevance to clinical research, patient care, safety, and
quality improvement.
Goals
• Support surgical faculty and trainees interested in HSR, and provide house staff with skills to
engage in outcomes research.
• Provide resources for current and future investigators by establishing a central library of
current datasets and other pertinent software.
• Recognize excellence in surgical outcomes research by highlighting work done both within the
Department of Surgery and by nationally prominent visiting professors.
The Duke SCORES Scholars Program provides funding of up to $15,000 per project for 12 months
to catalyze investigations of key questions in surgical outcomes research. The goals of this
program are to foster new collaborations among Duke researchers, support research teams in
obtaining preliminary data that will be used to apply for larger awards, and provide opportunities
for mentoring and training for junior faculty, residents and medical students.
26
Departmental
Infrastructure for
Clinical Research
The Surgery Clinical Research Unit (CRU) operates within the Surgery Office of Clinical Research
(“SoCR”). The SoCR was established to provide turn-key clinical trial support for the Department of
Surgery’s principal investigators, trainees, clinical research coordinators, and study sponsors.
The SoCR assists with protocol design, budget development, sponsor negotiations, site feasibility
assessments, study operations, staffing support, database design and data integrity, regulatory
document preparation, submission compliance, research practice training, clinical audit, and
serves as a liaison with the contracts and finance offices as well as inter-departmental resources.
In keeping with the mission of Duke Medicine and the Department of Surgery, the SoCR is
committed to providing training of tomorrow’s leaders and the conduct of innovative research
that impacts healthcare outcomes for all patients.
Duke Surgery residency and fellowship programs offer opportunities to be involved in clinical
research. Please contact the Residency or Fellowship Coordinator about the research training
available and required in your residency or fellowship program.
27
Departmental
Infrastructure for
Clinical Research
The SSCRSS supports quality translational science through validated, standardized methodology
and protocols that are implemented across studies, reducing non-relevant variability in results.
To support this standardization, the core is in compliance with internationally-recognized Good
Clinical Laboratory Practices and 21 CFR Part 11. Reproducibility across supported research is
achieved through continued monitoring of the quality system by the Quality Assurance for Duke
Vaccine Immunogenicity Programs (QADVIP), an independent quality assurance unit providing
support to the SSCRSS.
The SSCRSS supports more than 30 clinical trials and collaborative studies, including National
Institute of Health (NIH), Food and Drug Administration (FDA), Department of Defense (DoD)
and industry studies and operates as a core facility for multiple multicenter studies providing
a single point of contact for feedback in protocol development, standardized collection,
processing methods, sample preparation and sample shipping, receiving and distribution. The
SSCRSS anticipates supporting over 56 studies over the next year and is currently supporting 32
investigators over 3 departments and 20 divisions within the Duke University Medical Center.
28
Departmental
Infrastructure for
Clinical Research
29
Residents
Residency Programs
30
Residents
Duke surgical residents experience a wide variety of educational settings by rotating through
Durham Regional, Duke Raleigh, Durham VA, and Asheville VA hospitals. Residents during their
first two years develop a solid foundation in patient care, ICU management, and consultations.
Junior residents finish their first two years with well over the minimum 250 operative cases
required by the ACGME, thanks in part to the Department’s growing number of excellent
physician-extenders.
Junior and lab residents will also develop their operative skills by participating in an advanced
simulation curriculum developed with input from faculty and residents. Our innovative simulation
program optimizes the educational experience to better suit residents’ schedules and shifts
it earlier in our residents’ training, where it is most effective. This curriculum allows residents
to master complex operative skills earlier in their training and safely prepares them for the
autonomy and operative responsibilities required during their upper-level rotations.
Senior residents lead inter-disciplinary surgical teams and learn to manage the complex, high-
acuity patient services one would expect at a high-volume academic institution. Their role is to
act predominantly as service chiefs for rotations in hepatobiliary, surgical oncology, trauma/acute
care, pediatric, transplant, thoracic, vascular, colorectal, breast, and endocrine surgery. At Duke
University Hospital, all services use a night float system, which means patient care is covered by
a consistent overnight team led by a night in-house chief. By graduation, Duke general surgery
residents have an excess of operative experience well beyond the ACGME requirement of 850
cases minimum.
It is not just the case numbers, the challenging patients, or the simulation curriculum that creates
a great surgeon. It is the intangible, un-quantifiable attributes of a program that shape trainees
not only into skillful technicians but also cultivates them into future surgical leaders. At Duke, our
greatest unmeasurable strength is our faculty and residents. The supportive leadership of our
faculty and the enthusiastic involvement of our residents make Duke an exceptional place to train
as a surgeon and develop as a leader.
31
Residents
The Surgical Education Research Group (SERG) was cofounded in 2015 by Dr. John Migaly
(Program Director) and Dr. Shanna Sprinkle (PGY-6). With the support of the faculty and
department, SERG from the beginning has been a resident- and medical student-driven endeavor.
The group provides a collaborative space to brainstorm and develop projects that advance
surgical education at our institution and beyond. SERG now has the support of a talented
research coordinator to help with logistics and administrative duties, allowing students and
residents to focus on idea development and methodology.
Objectives
• PROMOTE knowledge of high-quality education research and methodologies.
• ESTABLISH education research as a valuable pillar in the Duke Surgery research enterprise.
32
Residents
Program Highlights
In its short history, the group has obtained three separate grants, presented at several national
meetings, and developed an iPhone application, podcast, and several devices. This past Spring
the group ran the STAR course (Surgical Technique and Review Course) for the second year in a
row. The SERG group will also be organizing a two-day seminar for general surgery residents to
foster the development of skills geared towards teaching medical students
We have ongoing projects within all realms of surgical education, working to improve surgical
knowledge, curriculums, technical skills, and behavior. As we continue to grow, we look forward to
exploring new, novel ideas that will keep Duke at the forefront of surgical education research!
Contact Us
If you would like to join, collaborate, or learn more about Duke SERG, please email Morgan Cox at
morgan.cox@duke.edu or Shanna Sprinkle at shanna.sprinkle@duke.edu.
33
Residents
National
Average Duke
Academic Year
Length of accredited training 5 5
Required length 7
Residents
Average number of residents/fellows 31.1 48
Faculty
Average number of full-time physician faculty 31.5 73
34
Residents
Conferences
Schedule
Monday
Intern (PGY-1) Conference (Intern School) 5:30 p.m. – 6:30 p.m.
Tuesday
Duke Regional Hospital Conference 6:30 a.m. – 7:30 a.m.
Wednesday
Surgical D&C Case Conference* 6:00 a.m. – 7:00 a.m.
Surgical Grand Rounds* 7:00 a.m. – 8:00 a.m.
SCORE Curriculum Conference* 8:15 a.m. – 9:15 a.m.
Simulation Lab* 9:30 a.m. – 12:30 p.m.
Thursday
Durham VA Conference 7:00 a.m. – 8:00 a.m.
Duke Raleigh Hospital Conference 7:00 a.m. – 8:00 a.m.
Chairman Walk Rounds 4:30 p.m. – 5:30 p.m.
Friday
Asheville VA Conference 7:30 a.m. – 8:30 a.m.
Chief Resident Conference 4:30 p.m. – 5:30 p.m.
Exceptions: ACU, SICU residents, Thoracic SAR, JTP residents rotating on cardiac, residents rotating at
Asheville
SEAL
Required for all residents when assigned, including DRH and Duke Raleigh.
Exceptions: Any resident who was on a night shift the night prior, ACU, SICU residents, ThoracicSAR, JTP
residents rotating on cardiac, residents rotating at Asheville
Chairman’s Rounds
All research residents and all clinical residents (at Duke and the Durham VA) not in the operating room
or engaged in urgent clinical care.
Educational Laboratories
Duke Vivarium
3D Printing Lab
36
Residents
Innovate MD
InnovateMD provides opportunities via two separate pathways: (1) a competitive one-year
full-immersion fellowship for clinical trainees who will learn the process of medical device
development from the early stages of needs finding to commercialization and starting a business,
or (2) as a centralized educational platform for trainees and faculty outside of the fellowship
program to learn this process with the goal of forming a team around a specific clinical project.
The mission of InnovateMD is to serve as an educational “hub” that complements the projects and
initiatives of MEDx and the various clinical departments at Duke Health.
37
Residents
Innovate MD
Program Highlights
Program Leadership
Advisory Team
Ongoing Collaborations
• Duke MEDx
• Department of Surgery
• Pratt School of Engineering
• Duke Innovation & Entrepreneurship
• Duke Institute for Health Innovation
38
Residents
Ergonomics Program
In collaboration with the Duke Ergonomics Division and with support from Department of
Surgery Chair Dr. Allan Kirk, several General Surgery residents initiated a program to teach junior
residents and medical students about proper positioning in the OR. The program includes an
ergonomic loupe fitting initiative currently in development, ergonomics labs with residents, one-
on-one observation of the chief residents, and coach training for the rising chief residents.
As part of the program, each resident is fitted with loupes that sit at a proper declination angle to
minimize neck flexion. Maintaining neck flexion at less than or equal to 25 degrees can prevent
spine and neck strain during long stints in the OR. Additionally, the ergonomics team suggests
that residents use anti-fatigue mats and take microbreaks for stretches to reduce the risk of
injury.
39
Residents
Residents
Duke Surgery residents are standouts in their field. Graduates consistently go on to land
prestigious fellowships and highly sought-after clinical positions and academic professorships.
Some focus on teaching, garnering awards for training and mentoring the next generation of
surgeons. Others devote their careers to research, making significant advancements in surgical
care.
The residents are typically highly productive during their time in training. Most establish
themselves as bona fide authorities in a chosen field and exemplify this through significant
contribution to the medical literature. This productivity indicates not only the high level of talent
and ingenuity typical of the Duke Surgery resident, but also speaks to the quality of mentorship in
time management, prioritization, and other skills critical to academic success delivered during the
residency period. The publications of the Chief Residents in Surgery from the past two years (over
200) are presented as an example of the ongoing productivity of Duke surgical trainees.
40
Residents
Residents’ Lounge
In 2017, Duke Surgery opened a lounge specifically for its residents, and designed to allow
residents to make the most of their experience at Duke. Featuring a lounge area, kitchen,
conference rooms, and work stations, the more than 150 residents in Duke Surgery have a multi-
use space to meet with colleagues and rejuvenate.
41
Residents
The most important metric of a residency program is the success of its trainees. This is best
captured by the most prominent position in one’s career (for established surgeons) and the
initial position obtained after residency (either faculty or fellowship for junior faculty). To assist
applicants in understanding the breadth and height of the careers of trainees of the Department
of Surgery, we provide the most prominent positions of all graduates of the program since
1970, and the initial appointments of new graduates for the past 20 years. You will note that
approximately 70 percent of graduates follow academic careers, with numerous individuals rising
to the level of Department Chair, Dean, and other executive leadership positions.
2018
Mithun Shenoi Colon and Rectal Surgery Colon and Rectal Surgery
Fellowship, Indiana Fellowship, Indiana University
University School of School of Medicine
Medicine
42
Residents
43
Residents
2017
44
Residents
2016
45
Residents
2015
2014
46
Residents
2014
2013
47
Residents
2013
2012
2011
2010
2010
2009
50
Residents
2009
2008
51
Residents
2008
2007
52
Residents
2006
2005
53
Residents
2005
2004
Patrick Domkowski Private practice, Palm Bay, FL Private Practice, Sebastian River
Medical Center, Sebastian, FL
54
Residents
2003
2002
55
Residents
2002
Aurora Pryor MIS Fellowship, Duke Univer- Professor of Surgery and Vice
sity Medical Center Chair for Clinical Affairs, Chief
General Surgery Division,
Director Bariatric and Meta-
bolic Weight Loss Center, Stony
Brook School of Medicine
2001
56
Residents
2001
2000
57
Residents
2000
1999
Bryan Weidner Surgical Critical Care Fellowship, Chief of Pediatric Surgery and
Duke University Medical Center Surgeon-in-Chief, Children’s
Hospital at Sacred Heart,
Pensacola, FL
58
Residents
1999
1998
59
Residents
1998
1997
60
Residents
1997
1996
61
Residents
1996
1995
62
Residents
1995
1994
Andrew Davidoff Chair of Surgery, St. Jude’s Children Research Hospital, Memphis, TN
Stanley A. Gall Jr. Prairie Thoracic and Cardiovascular Surgeons, Prairie Heart
Institute, Springfield Illinois
63
Residents
1994
1993
64
Residents
1992
1991
Robert L. Quigley Regional Medical Director and Senior Vice President of Medical
Assistance, Americas at International SOS
65
Residents
1990
1989
Ralph H. Damiano Jr. Professor of Surgery and Chief Division of Cardiothoracic Surgery,
Washington University School of Medicine
66
Residents
1989
1988
T. Bruce Ferguson East Carolina Heart Institute at ECU, Brody School of Medicine
1987
67
Residents
1987
1986
Peter Van Trigt III Triad Cardiac & Thoracic Surgeons, Greensboro, NC
1984
Walter R. Chitwood Director, East Carolina Heart Institute; Senior Associate Vice
Jr. Chancellor for Health Sciences, Brody School of Medicine
68
Residents
1984
Richard A. Hopkins Endowed Chair in Pediatric Surgery Research and Director, Cardiac
Regenerative Surgery Research Laboratories, Children’s Mercy
Kansas City
1983
Charles E. Cox CEO, Breast Health CRISP (Clinical and Research Integrated
Strategic Program); McCann Foundation Endowed Professor of
Breast Surgery, USF Health, Tampa, FL
69
Residents
1983
1980
70
Residents
1980
Jeffrey A. Norton Professor of Surgery and Chief of Oncologic and General Surgery,
Stanford University
1979
1978
James L. Cox Chairman and Chief Executive Officer, World Heart Foundation; Emeri- tus
Professor of Surgery, Washington University School of Medicine
71
Residents
1978
Gregory S. Georgiade Professor of Surgery, Chief of Division of Plastic Surgery, and Vice
Chair of Department of Surgery, Duke University Medical Center
1977
1976
M. Wayne Flye Chief, Thoracic Surgery, St. Louis Veterans Administration Hospital;
Chief of Surgery, Saint Louis Connect Care Health Systems
72
Residents
1976
Robert P. Barnes Department Chair, Cardiovascular Services, St. Luke’s Hospital, Boise, ID
1975
1974
1973
1974
Name Most Prominent Position
73
Residents
1972
1971
1970
74
Residents
75
Residents
EHSAN BENRASHID, MD
Education:
M.D., University of Virginia School of Medicine, 2012
Training:
General Surgery (PGY1) 6/25/2012-6/30/2013
General Surgery (PGY2) 7/1/2013-6/30/2014
Surgery Research Fellowship – Duke (PGY3) 7/1/2014-6/30/2015
Surgery Research Fellowship – Duke (PGY4) 7/1/2015-6/30/2016
General Surgery (PGY5) 7/1/2016-6/30/2017
General Surgery (PGY6) 7/1/2017-6/30/2018
General Surgery (PGY7) 7/1/2018-Present
Research Interests:
Abdominal and Thoracoabdominal Aortic Disease, Peripheral Arterial Disease
Clinical Interests:
Vascular Surgery, Peripheral Arterial Disease
Publications:
Wu B, Lu P, Benrashid E, Malik S, Ashar J, Doran TJ, Lu QL Dose-dependent restoration
of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered
morpholino. Gene Therapy 2010 Jan; 17 (1): 132-140.
Hu Y, Wu B, Zillmer A, Lu P, Benrashid E, Wang M, Doran T, Shaban M, Wu X, Long Lu
Q. Guanine Analogues Enhance Antisense Oligonucleotide-induced Exon Skipping in
Dystrophin Gene In Vitro and In Vivo. Molecular Therapy 2010 Apr; 18(4): 812-8.
*Wu B, *Benrashid E, Lu P, Cloer C, Zillmer A, Shaban M, Lu QL. Targeting skipping of
human dystrophin exons in transgenic mouse model systemically for antisense drug
development. PLoS ONE 2011; 6(5): e19906 (*co-first authorship)
Benrashid E and Lawson JH. Chapter 11: Uncommon Procedures for the Difficult Dialy-
sis Access Patient. Current Vascular Surgery 2014. PMPH (Shelton, CT USA)
Gilmore B, Benrashid E, Youngwirth LM, Lawson JH. Paradoxical embolus following
percutaneous thrombectomy of Hemodialysis Reliable Outflow graft. J Vasc Access 2015
Nov-Dec; 16(6): 533-6.
Stone ML, LaPar DJ, Benrashid E, Scalzo DC, Mulloy DP, Ailawadi G, Kron IL, Bergin JD,
Blank RS, Kern JA. Ventricular assist devices and increased blood product utilization for
cardiac transplantation. J Card Surg 2015; 30(2): 194-200
Benrashid E, Adkar SS, Bennett KM, Zani S, Cox MW. Total laparoscopic retrieval of infe-
rior vena cava filter. SAGE Open Medical Case Reports. doi: 10.1177/2050313X15597356
Benrashid E, McCoy CC, Rice HE, Shortell CK, Cox MW. Mycotic saccular abdominal
aortic aneurysm in an infant after cardiac catheterization: a case report. Ann Vasc Surg
2015 Oct; 29(7): 1447.e5-1447.e11.
Benrashid E, McCoy CC, Youngwirth LM, Kim J, Manson RJ, Otto JC, Lawson JH. Tis-
sue engineered vascular grafts: origins, development, and current strategies for
clinical application. Methods 2015 Jul 25. Pii: S1046-2023(15)30033-5. doi: 10.1016/j.
ymeth.2015.07.014
Benrashid E, Ranney DN, and Lawson JH. Chapter 20: Bioengineered Vascular Access
Grafts. Current Vascular Surgery 2015. PMPH (Shelton, CT USA)
Benrashid E, Wang H, Keenan JE, Andersen ND, Meza JM, Hughes GC. Evolving practice
pattern changes and outcomes in the era of hybrid aortic arch repair. J Vasc Surg 2016
Feb; 63(2): 323-331.e1.
Sun Z, Adam MA, Kim J, Nussbaum DP, Benrashid E, Mantyh CR, Migaly J. Determining
the optimal timing for initiation of adjuvant chemotherapy after resection for stage II
76
Residents
and III colon cancer. Dis Colon Rectum. 2016 Feb; 59(2): 87-93.
Andersen ND, Benrashid E, Ross AK, Pickett LC, Smith PK, Daneshmand MA, Schroder
JN, Gaca JG, Hughes GC. The utility of the aortic dissection team: outcomes and insights
after a decade of experience. Ann Cardiothorac Surg 2016 May; 5(3): 194-201.
Benrashid E, Wang H, Andersen ND, Keenan JE, McCann RL, Hughes GC. Complimentary
roles of open and hybrid approaches to thoracoabdominal aortic aneurysm repair. J
Vasc Surg. 2016 Nov; 64(5): 1228-38.
Keenan JE, Benrashid E, Kale E, Nicoara A, Husain AM, Hughes GC. Neurophysiologic
intraoperative monitoring during aortic arch surgery. Semin Cardiothorac Vasc Anesth.
2016 Dec; 20(4): 273-82.
Turley RS, Adkar SA, Benrashid E, Lagoo S, Shortell CK, Mureebe L. Peri-operative
optimization of geriatric lower extremity bypass in the era of increased performance
accountability. Ann Vasc Surg 2017 Jan; 38: 248-54.
Adkar SS, Turley RS, Benrashid E, Cox M, Mureebe L, Shortell CK. Laparotomy during
endovascular repair of ruptured abdominal aortic aneurysms increases mortality. J Vasc
Surg 2017 Feb; 65(2): 356-61.
Gulack BC, Benrashid E, Jaquiss RDB, Lodge AJ. Pulmonary valve replacement with a
Trifecta valve is associated with reduced transvalvular gradient. Ann Thorac Surg 2017
Feb; 103(2): 655-662.
Iribarne A, Keenan J, Benrashid E, Wang H, Meza JM, Ganapathi A, Gaca J, Kim HW, Hur-
witz LM, Hughes GC. Imaging surveillance after proximal aortic surgery: is it necessary?
Ann Thorac Surg 2017 Mar; 103(3): 734-41.
Benrashid E, Youngwirth LM, Mureebe L, Lawson JH. Operative and perioperative man-
agement of infected arteriovenous grafts. J Vasc Access 2017 Jan; 18(1): 13-21.
Kim J, Sun Z, Benrashid E, Southerland KW, Lawson JH, Fleming GA, Hill KD, Tracy ET.
The impact of femoral arterial thrombosis in pediatric cardiac catheterization: a nation-
al study. Cardiol Young 2017 Jul; 27(5): 912-7.
Kim J, Sun Z, Leraas HJ, Nag UP, Benrashid E, Allori AC, Pabon-Ramos WM, Rice HE,
Shortell CK, Tracy ET. Morbidity and healthcare costs of vascular anomalies: a national
study. Pediatr Surg Int 2017 Feb; 33(2): 149-54.
Ranney DN, Benrashid E, Meza JM, Keenan JE, Daneshmand MA. Central cannulation
as a viable alternative to peripheral cannulation in extracorporeal membrane oxygen-
ation. Semin Thorac Cardiovasc Surg 2017 Summer; 29(2): 188-95.
Ranney DN, Cox ML, Yerokun B, Benrashid E, McCann RL, Hughes GC. Long-term results
of endovascular repair for descending thoracic aortic aneurysms. J Vasc Surg 2018 Feb;
67(2): 363-8.
Ranney DN, Benrashid E, Meza JM, Keenan JE, Bonadonna D, Mureebe L, Cox MW,
Daneshmand MA. Vascular complications and use of a distal perfusion cannula in femo-
rally cannulated patients on extracorporeal membrane oxygenation. ASAIO J 2017 Sep.
[Epub ahead of print]
Wang H, Wagner M, Benrashid E, Keenan J, Wang A, Ranney D, Yerokun B, Gaca J,
McCann RL, Hughes GC. Outcomes of reoperation after acute type A aortic dissection:
implications for index repair strategy. J Am Heart Assoc 2017 Oct; 6(10): pii:e006376
Ongele MO, Benrashid E, Gilmore BF, Schroder J, Hartwig M, Zani S Jr. Robot-assisted
repair of diaphragmatic hernias following ventricular assist device implantation. J Surg
Case Rep 2018 Feb 21; 2018(2): rjy016
Ranney DN, Yerokun BA, Benrashid E, Bishawi M, Williams A, McCann RL, Hughes GC.
Outcomes of planned 2-stage hybrid aortic repair with Dacron replaced proximal land-
ing zone. Ann Thorac Surg 2018 May. [Epub ahead of print]
Benrashid E, Youngwirth LM, Turley RS, Mureebe L. Chapter 196: Venous Thromboem-
bolism: Prevention, Diagnosis, and Management. Current Surgical Therapy. 12th Ed.
Elsevier (Philadelphia, PA USA)
Gage S, Benrashid E, Youngwirth LM, Lawson JH. Hemodialysis Grafts. Hemodialysis
77
Residents
Training:
General Surgery (PGY1) 6/21/2013-6/30/2014
General Surgery (PGY2) 7/1/2014-6/30/2015
General Surgery (PGY3) 7/1/2015-6/30/2016
Surgery Research Fellowship – Duke (PGY4) 7/1/2016-6/30/2017
Jt General Surgery & Thoracic Surgery (PGY5) 7/1/2017-6/30/2018
Jt General Surgery & Thoracic Surgery (PGY6) 7/1/2018-Present
Publications:
Szasz T, Linder AE, Davis RP, Burnett R, Fink G, and Watts SW. Allopurinol Does Not
Decrease Blood Pressure or Prevent the Development of Hypertension in the DOCA-salt
Rat Model. J. Cardiovasc Pharmacol. 2010 Sep. 22. PMID:20881613
Watts SW, Davis RP. 5-Hydroxytrptamine Receptors in Hypertension: An Arterial Focus.
Cardiovasc Ther. 2010 Apr 28. PMID: 20433685
Linder AE, Davis RP, Burnett R, Watts SW. Comparison of the function of the serotonin
transporter in vasculature of male and female rats. Clin Exp Pharmacol Physiol. 2011
May; 38(5): 314-22. PMID: 21371073
Davis RP, Linder AE, Watts SW. Lack of the serotonin transporter (SERT) reduces the
ability of 5-hydroxytryptamine to lower blood pressure. Nauyn-Schmiedeberg Arch
Pharmacol. 2011 May; 383(5): 543-6. Epub 2011 Mar 30. PMID: 21448568.
Tan T, Watts SW, Davis RP (2011). Drug delivery: enabling technology for drug discov-
ery and development. iPRECIO® Micro Infusion Pump: Programmable, refillable and
implantable. Front. Pharmacol. 2:44. Epub 2011 Jul 29. PMID: 21863140.
Watts SW, Morrison MF, Davis RP, Barman SM. Serotonin and Blood Pressure Regula-
tion. Pharmacol Rev. 2012 Apr; 64(2): 359-88. Epub 2012 Mar 8. PMID: 22407614.
Davis RP, Pattison J, Thompson JM, Tinkov R, Scrogin KE, Watts SW. 5-hydroxytrypt-
amine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial
relaxation is not involved. BMC Pharmacol. 2012 May 6; 12:4. PMID: 22559843.
Davis RP, Szasz T, Garver H, Burnett R, Tykocki N, Watts SW. One-month serotonin
infusion results in a prolonged fall in blood pressure in the male deoxycorticosterone
acetate (DOCA)-salt rat. ACS Chem Neurosci. 2013 Jan 16; 4(1). PMID: 23336053.
Szasz T, Davis RP, Garver HS, Burnett R, Fink G, Watts SW. Long-term inhibition of xan-
thine oxidase by febuxostat does not decrease blood pressure in deoxycorticosterone
acetate (DOCA)-salt hypertensive rats. PLoS One. 2013; 8(2):e56046. PMID: 23393607.
78
Residents
Neely RC, Davis RP, Stephens EH, Takayama H, Khalpey Z, Ginns J, Lee SH, Chen J.
Ventricular assist device for failing systemic ventricle in an adult with prior mustard
procedure. Ann Thorac Surg. 2013 Aug; 96(2):691-3. PMID: 23910115.
Davis RP, Kilian A, Timek T, Cohle SD, Hooker DL. Complete LVOT obstruction fol-
lowing aortic valve replacement after HeartMate II implantation. J Card Surg. 2014
May;29(3):432. PMID: 24304173
Darios E, Barman S, Orer H, Morrison S, Davis RP, Seitz B, Watts S. 5-Hydroxytryptamine
does not reduce sympathetic nerve activity or neuroeffector function in the splanchnic
circulation. Eur J Pharmacol. 2015 May;754:140-7.
Davis RP, Andersen ND, Ganapathi AM, Hughes GC. Repair of bicuspid aortic valve syn-
drome with anomalous right coronary artery in osteogenesis imperfecta. J Heart Valve
Dis. 2015 Nov;24(6):666-668. PMID: 27997768.
Cox M, Yang CF, Speicher P, Fitch Z, Davis RP, D’Amico TD, Harpole D, Berry M. The Role
of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmo-
nary Lepidic Adenocarcinoma. J Thorac Oncol. 2017, Jan 8. PMID: 28082103.
Mulvihill MS, Yerokun BA, Davis RP, Ranney DN, Daneshmand MA, Hartwig MG. Ex-
tracorporeal membrane oxygenation following lung transplantation: indications and
survival. J Heart Lung Transplant 2017 Jul1 [Epub ahead of print]. PMID: 28712677.
Ezekian B, Mulvihill MS, Freischlag K, Yerokun BA, Davis RP, Hartwig MG, Knectle SJ, Bar-
bas AS. Elevated HbA1c in donor organs from patients without a diagnosis of diabetes
portends worse liver allograft survival. Clin Transplant. 2017 Sep;31(9). PMID: 28667782
Chang, J, Bell S, Davis RP, Sanders, N, Holzknecht M, Barbas A, Parker W, Lin S. Early
Immune Response to Acute Gastric Fluid Aspiration in a Rat Model of Lung Transplanta-
tion. Exp Clin Transplant. 2018 Apr 26. PMID: 29697356
Samy, KP, Davis RP, Gao Q, Martin BM, Song M, Cano J, Farris AB, McDonald A, Gall EK,
Dove CR, Leopardi FV, How, T, Williams KD, Devi GR, Collins BH, Kirk AD. Early Barriers
to Neonatal Porcine Islet Engraftment in a Dual Transplant Model. Am J Transplant.
2018 Apr; 18(4):998-1006. PMID: 29178588.
Eppensteiner, J, Davis RP, Barbas A, Kwun, J, Lee J. Immunothrombotic activity of DAMPs
and Extracellular Vesicles in Secondary Organ Failure induced by Trauma and Sterile
Insults. Front Immunol. 2018 Feb 8;9:190. PMID: 29472928.
Gao Q, Mulvihill MS, Scheuermann U, Davis RP, Yerxa J, Yerokun BA, Hartwig MG, Sudan
DL, Knechtle SJ, Barbas AS. Improvement in Liver Transplant Outcomes From Older
Donors: A US National Analysis. Ann Surg. 2018 Jun 28. [Epub ahead of print]. PMID:
29958229
Bendersky, VA, Mulvihill MS, Yerokun BA, Ezekian B, Davis RP, Hartwig MG, Barbas AS.
Elevated Donor Hemoglobin A1C Impairs Kidney Graft Survival From Diabetic Deceased
Donors: A National Analysis. Accepted to Experimental and Clinical Transplantation May
4th 2018.
Agarwal R, Kyvernitakis A, Soleimani B, Milano C, Kennedy J, Davis RP, Benza R, Mora-
ca R, Bailey S. Clinical Experience and Outcomes of HeartMate II to HeartWare Left
Ventricular Assist Device Exchange: A Multicenter Experience of 24 Cases - Submitted to
Annals of Thoracic Surgery.
79
Residents
JINA KIM, MD
Education:
M.D., University of Michigan Medical School, 2012
Training:
General Surgery (PGY1) 6/25/2012-6/30/2013
General Surgery (PGY2) 7/1/2013-6/30/2014
Surgery Research Fellowship – Duke (PGY3) 7/1/2014-6/30/2015
Surgery Research Fellowship – Duke (PGY4) 7/1/2015-6/30/2016
General Surgery (PGY5) 7/1/2016-6/30/2017
General Surgery (PGY6) 7/1/2017-6/30/2018
General Surgery (PGY7) 7/1/2018-Present
Research Interests:
Endocrine surgery with focus on pediatric endocrine surgery, thyroid cancer
Clinical Interests:
Understanding age-based differences in cancer outcomes, quality improvement in
cancer care
Publications:
You J, Li Q, Wu C, Kim J, Ottinger M, and Howley PM. Regulation of Aurora B expression
by the bromodomain protein Brd4. Molecular and Cellular Biology 29.18 (2009): 5094-
5103.
An SS, Kim J, Ahn K, Trepat X, Drake KJ, Kumar S, Ling G, Purington C, Rangasamy T,
Kensler TW, Mitzner W, Fredberg JJ, Biswal S. Cell stiffness, contractile stress and the
role of extracellular matrix. Biochemical and Biophysical Research Communications
382.4 (2009): 697-703.
Kim J, Jarboe MD, Arnold MA, DiPietro MA, Bloom DA, Teitelbaum DH. Biliary duplication
cyst with heterotopic gastric mucosa resulting in obstruction of the biliary system: a
case report. Journal of Pediatric Surgery 47.6 (2012): e5-e8.
Yang Z, Maher JR, Kim J, Selim A, Levinson H, Wax A. Evaluation of burn severity in vivo
in a mouse model using spectroscopic optical coherence tomography. Biomedical Op-
tics Express 6.9 (2015): 3339-45.
Kim J, Brown W, Maher J, Levinson H, Wax A. Functional optical coherence tomography:
principles and progress. Physics in Medicine and Biology 60 (2015): R211-237.
Benrashid E, McCoy CC, Youngwirth LM, Kim J, Manson RJ, Otto JC, Lawson JH. Tissue
engineered vascular grafts: origins, development and current strategies for clinical
application. Methods 99 (2016): 13-9.
Adam MA, Lee L, Kim J, Shenoi M, Mallipeddi M, Aziz H, Stinnett S, Sun Z, Mantyh CM,
Thacker JKM. Alvimopan provides additional improvement in outcomes and cost savings
in enhanced recovery colorectal surgery. Annals of Surgery 264.1 (2016): 141-6.
Sun Z, Adam MA, Kim J, Hsu SD, Palta M, Czito BG, Migaly J, Mantyh CR. Effect of com-
bined neoadjuvant chemoradiation on overall survival for patients with locally ad-
vanced rectal cancer. Journal of Clinical Oncology 34.4 (2016): 657.
Sun Z, Kim J, Adam M, Nussbaum DP, Speicher PJ, Mantyh CR, Migaly J. National
longterm outcomes of minimally invasive versus open low anterior resection for rectal
cancer. Annals of Surgery 263.6 (2016): 1152-1158.
Sun Z, Adam MA, Kim J, Nussbaum DP, Benrashid E, Huang ES, Mantyh CR, Migaly J. De-
termining the optimal timing for initiation of adjuvant chemotherapy after resection for
stage II and III colon cancer. Diseases of Colon and Rectum 59.2 (2016): 87-93.
Gulack BC, Rialon KL, Englum BR, Kim J, Talbot LJ, Adibe OO, Rice HE, Tracy ET. Factors
associated with survival in pediatric adrenocortical carcinoma: An analysis of the na-
tional cancer database (NCDB). Journal of Pediatric Surgery 51.1 (2016): 172-7.
Sun Z, Adam MA, Kim J, Shenoi M, Migaly J, Mantyh CR. Optimal timing to surgery after
80
Residents
neoadjuvant chemotherapy for locally advanced rectal cancer. Journal of the American
College of Surgeons 222.4 (2016): 367-74.
Adam MA, Sun Z, Kim J, Migaly J, Mantyh CR. Thirty-day mortality underestimates
incidence of death after colorectal surgery for cancer. Gastroenterology 150.4 (2016):
s1199.
Yerokun B, Adam MA, Sun Z, Kim J, Sprinkle S, Migaly J, Mantyh CR. Does conversion in
laparoscopic colectomy portend an inferior oncologic outcome? Results from 104,400
patients. Journal of Gastrointestinal Surgery 20.5 (2016): 1042-8.
Ezekian B, Sun Z, Adam MA, Kim J, Turner MC, Gilmore BF, Ong CT, Mantyh CR, Migaly
J. Robotic-assisted versus laparoscopic colectomy results in increased operative time
without improved perioperative outcomes. Journal of Gastrointestinal Surgery 20.8
(2016): 1503-1510.
Adam MA, Sun Z, Kim J, Thacker JK. Reply to letter: alvimopan is associated with im-
proved outcomes and cost savings in enhanced recovery colorectal surgery protocols.
Annals of Surgery 266.6 (2016): e82.
Gurien LA, Blakely ML, Russell RT, Streck CJ, Vogel AM, Renaud EJ, Savoie KB, Dassinger
MS, Speck KE, Nice TR, Kim J, Adibe OO, Calder BW, Leys CM, Rogers AP, DeUgarte DA,
Williams RF, St. Peter SD, Parrish DW, Haynes JH, Rothstein DH, Jen HC, Tang X. Re-
al-time ultrasound for central venous catheter placement in children: a multiinstitution-
al study. Surgery 160.6 (2016): 1605-1611.
Gilmore BF, Sun Z, Adam MA, Kim J, Ezekian B, Ong C, Migaly J, Mantyh C. Hand-assisted
laparoscopic versus standard laparoscopic colectomy: are outcomes and operative time
different? Journal of Gastrointestinal Surgery 20.11 (2016): 1854-1860.
Sun Z, Adam MA, Kim J, Czito B, Mantyh CR. Migaly J. Intensity-modulated radiation
therapy is not associated with either short-term or long-term benefit over 3D-confor-
mal radiotherapy for rectal cancer. Journal of Gastrointestinal Surgery 150.4 (2016):
S1175–S1176.
Kim J, Sun Z, Gulack BC, Adam MA, Mosca PJ, Rice HE, Tracy ET. Sentinel lymph node
biopsy is a prognostic measure in pediatric melanoma. Journal of Pediatric Surgery 51.6
(2016): 986-990.
Kim J, Sun Z, Englum BR, Allori AC, Adibe OO, Rice HE, Tracy ET. Laparoscopy is safe in
infants and neonates with congenital heart disease: A national study of 3,684 patients.
Journal of Laparoendoscopic & Advanced Surgical Techniques 26.10 (2016): 836-839.
Leraas HJ, Kim J, Sun Z, Nag UP, Ezekian BD, Kamyszek RW, Gulack BC, Rice HE, Adibe
OO, Borst AJ, Rothman JA, Tracy ET. Postoperative venous thromboembolism in children
is increased in setting of cancer or infection. Blood 128.22 (2016): 2391.
Turner MC, Adam MA, Sun Z, Kim J, Ezekian B, Mantyh C, Migaly J. Insurance status, not
race, is associated with use of minimally invasive approach for rectal cancer. Annals of
Surgery 265.4 (2017): 774-781.
Sun Z, Gilmore B, Adam MA, Kim J, Hsu SD, Migaly J, Mantyh CR. Adjuvant chemotherapy
after preoperative chemoradiation improves survival in patients with locally advanced
rectal cancer. Diseases of Colon and Rectum 60.10 (2017): 1050-1056.
Ezekian B, Englum BR, Gilmore BF, Kim J, Leraas HJ, Rice HE. Onychocryptosis in the
pediatric patient: review and management techniques. Clinical Pediatrics 56.2 (2017):
109-114.
Leraas HJ, Ong CT, Sun Z, Adam MA, Kim J, Gilmore BF, Ezekian B, Nag UP, Mantyh CR,
Migaly J. Hand-assisted laparoscopic colectomy improves perioperative outcomes with-
out increasing operative time compared to the open approach: a national analysis of
8791 patients. Journal of Gastrointestinal Surgery 21.4 (2017): 684-691
Bendersky V, Sun Z, Adam MA, Rushing C, Kim J, Youngwirth L, Turner MC, Migaly J,
Mantyh CR. Determining the optimal quantitative threshold for preoperative albumin
level before elective colorectal surgery. 21.4 (2017): 692-699.
Turner MC, Adam MA, Sun Z, Kim J, Ezekian B, Yerokun BA, Mantyh CR, Migaly J. Re-
sponse to letter: comment on “Insurance Status, Not Race Is Associated With Use
81
Residents
of Minimally Invasive Surgical Approach for Rectal Cancer.” Annals of Surgery 267.2
(2017):774-781.
Freischlag K, Sun Z, Adam MA, Kim J, Palta M, Czito BG, Migaly J, Mantyh CR. Association
between incomplete neoadjuvant radiotherapy and survival for patients with locally
advanced rectal cancer. JAMA Surgery 152.6 (2017): 558-564.
Newcomb LK, Rhee EHJ, Bean SM, Kim J, Tracy ET, Kuller JA. Pregnancy complicated by
foetal abdominal mass: Fetiform teratoma versus foetus-in-fetu. Journal of Obstetrics
and Gynaecology 36.7 (2017): 815-817.
Sun Z, Adam MA, Kim J, Turner MC, Fisher DA, Choudhury KR, Czito BG, Migaly J, Mantyh
CR. Association between neoadjuvant chemoradiation and survival for patients with
locally advanced rectal cancer. Colorectal Disease 19.12 (2017): 1058-1066.
Ezekian B, Englum BR, Gilmore BF, Kim J, Leraas HJ, Driscoll TA, Tracy ET, Rice HE. Chil-
dren receiving hematopoietic stem cell transplantation are at increased risk of ony-
chocryptosis requiring surgical management. Journal of Pediatric Hematology/Oncology
39.7 (2017): e353-e356.
Nag UP, Leraas HJ, Kim J, Ezekian B, Reed CR, Lawson JH. Age associated with mortality
and outcomes in pediatric vascular trauma. Journal of Vascular Surgery 65.6 (2017):
187S-188S.
Leraas HJ, Kim J, Nag U, Ezekian B, Gulack BC, Reed CR, Rice HE, Tracy ET. Thoracoscopic
approach provides a safe alternative to open surgery in elective cases for newborns.
Journal of the American College of Surgeons 225.4 (2017): e140-141.
Ezekian B, Englum BR, Gilmore BF, Nag UP, Kim J, Leraas HJ, Routh JC, Rice HE, Tracy
ET. Renal medullary carcinoma: A national analysis of 159 patients. Pediatric Blood &
Cancer 64.11 (2017): e26609.
Watson JA, Englum BR, Kim J, Adibe OO, Rice HE, Shapiro ML, Daneshmand MA, Tracy
ET. Extracorporeal life support use in pediatric trauma: a review of the National Trauma
Data Bank. Journal of Pediatric Surgery 52.1 (2017): 136-139.
Englum BR, Rialon KL, Kim J, Shapiro ML, Scarborough JE, Rice HE, Adibe OO, Tracy
ET. Current use and outcomes of helicopter transport in pediatric trauma: a review of
18,291 transports. Journal of Pediatric Surgery 52.1 (2017): 140-144.
Gulack BC, Leraas HJ, Ezekian B, Kim J, Reed CR, Adibe OO, Rice HE, Tracy ET. Outcomes
following elective resection of congenital pulmonary airway malformations is equiv-
alent after 3 months of age and a weight of 5 kilograms. Journal of Pediatric Surgery
(2017 Oct 9): Epub ahead of print.
Leraas HJ, Kim J, Sun Z, Ezekian B, Gulack BC, Reed CR, Tracy ET. Solid pseudopapillary
neoplasm of the pancreas in children and adults: a national study of 369 patients. Jour-
nal of Pediatric Hematology/Oncology (2017 Dec 12): Epub ahead of print.
Adam MA, Turner MC, Sun Z, Kim J, Ezekian B, Migaly J, Mantyh CR. The appropriateness
of 30-day mortality as a quality metric in colorectal cancer surgery. American Journal of
Surgery 215.1 (2017): 66-70.
Ezekian B, Englum BR, Gulack BR, Rialon KL, Kim J, Talbot LJ, Adibe OO, Routh JC, Tracy
ET, Rice HE. Comparing oncologic outcomes after minimally invasive and open surgery
for pediatric neuroblastoma and Wilms tumor. Pediatric Blood & Cancer 65.1 (2017):
e26755.
Kim J, Sun Z, Benrashid E, Southerland K, Lawson JH, Fleming G, Hill K, Tracy ET. The im-
pact of femoral arterial thrombosis in cardiac catheterization of neonates and infants:
a study of 17,071 patients. Cardiology in the Young 27.5 (2017): 912-917.
Kim J, Sun Z, Gulack BC, Benrashid E, Nag UP, Miller MJ, Allori AC, Rice HE, Shortell CK,
Tracy ET. Morbidity and healthcare costs of vascular anomalies: a national study. Pedi-
atric Surgery International 33.2 (2017): 149-154.
Kim J, Sun Z, Ezekian B, Schooler GR, Prasad VK, Kurtzberg J, Rice HE, Tracy ET. Gallblad-
der abnormalities in children with metachromatic leukodystrophy. Journal of Surgical
Research 208 (2017): 187-191
Kim J, Turner MC, Rialon KL, Sinyard RD, Tracy ET, Rice HE, Adibe OO. Vascular compli-
82
Residents
cations in pediatric port removal. The American Surgeon 83.4 (2017): 143-145.
Kim J, Sun Z, Adam MA, Adibe OO, Rice HE, Roman SA, Tracy ET. Predictors of nodal
metastasis in pediatric differentiated thyroid cancer. Journal of Pediatric Surgery 52.1
(2017): 120-123.
DANIEL P. NUSSBAUM, MD
Education:
M.D., Un Of Southern California Keck School Of Medicine, 2011
Training:
General Surgery (PGY1) 6/27/2011-6/30/2012
General Surgery (PGY2) 7/1/2012-6/30/2013
Surgery Research Fellowship – Duke (PGY3) 7/1/2013-6/30/2014
Surgery Research Fellowship – Duke (PGY4) 7/1/2014-6/30/2015
Surgery Research Fellowship – Duke (PGY5) 7/1/2015-6/30/2016
General Surgery (PGY6) 7/1/2016-6/30/2017
General Surgery (PGY7) 7/1/2017-6/30/2018
General Surgery (PGY8) 7/1/2018-Present
Research Interests:
Comparative effectiveness research in surgical oncology; investigation of national qual-
ity initiatives in oncology; translational research in carcinogenesis, tumor progression/
metastasis, and anticancer drug responsiveness
Clinical Interests:
Gastrointestinal and hepatobiliary malignancies, soft tissue sarcomas
Publications:
Nath DS, Savla J, Khemani RG, Nussbaum DP, Greene CL, Wells WJ. Thoracic duct liga-
tion for persistent chylothorax after pediatric cardiothoracic surgery. Ann Thorac Surg.
2009 Jul;88(1):246-51; discussion 251-2. doi:10.1016/j.athoracsur.2009.03.083.
Nath DS, Carden AJ, Nussbaum DP, Shin AJ, Khemani RG, Starnes VA, Wells WJ.Can
the Kawashima procedure be performed in younger patients? Ann Thorac Surg. 2009
Aug;88(2):581-6; discussion 586-7. doi: 10.1016/j.athoracsur.2009.04.045.
Nath DS, Shin AJ, Nussbaum DP, Berman D, Starnes VA, Wells WJ. Ascending aortitis and
aortic valve endocarditis in an infant. J Thorac Cardiovasc Surg. 2010 Apr;139(4):e90-1.
doi: 10.1016/j.jtcvs.2009.04.030.
Nath DS, Nussbaum DP, Yurko C, Ragab OM, Shin AJ, Kumar SR, Starnes VA, Wells
WJ. Pulmonary homograft monocusp reconstruction of the right ventricular outflow
tract: outcomes to the intermediate term. Ann Thorac Surg. 2010 Jul;90(1):42-9. doi:
10.1016/j.athoracsur.2010.03.045.
Nussbaum DP, Bhattacharya SD, Jiang X, Cardona DM, Strickler JH, Blazer DG 3rd. Gas-
troesophageal heterotopia and HER2/neu overexpression in an adenocarcinoma arising
from a small bowel duplication. Arch Pathol Lab Med. 2014 Mar;138(3):428-31. doi:
10.5858/arpa.2012-0523-CR.
Speicher PJ, Goldsmith ZG, Nussbaum DP, Turley RS, Peterson AC, Mantyh CR. Ureter-
al stenting in laparoscopic colorectal surgery. J Surg Res. 2014 Jul;190(1):98-103. doi:
10.1016/j.jss.2014.02.025.
Nussbaum DP, Penne K, Speicher PJ, Stinnett SS, Perez A, White RR, Clary BM,
Tyler DS, Blazer DG 3rd. The role of clinical care pathways: an experience with distal
pancreatectomy. J Surg Res. 2014 Jul;190(1):64-71. doi:10.1016/j.jss.2014.02.026.
Speicher PJ, Nussbaum DP, Scarborough JE, Zani S, White RR, Blazer DG 3rd, Mantyh
CR, Tyler DS, Clary BM. Wound classification reporting in HPB surgery: can a single
word change public perception of institutional performance? HPB (Oxford). 2014
83
Residents
84
Residents
Lane WO, Cramer CK, Nussbaum DP, Speicher PJ, Gulack BC, Czito BG, Kirsch DG, Tyler
DS, Blazer DG 3rd. Analysis of perioperative radiation therapy in the surgical treatment
of primary and recurrent retroperitoneal sarcoma. J Surg Oncol. 2015 Sep;112(4):352-8.
doi: 10.1002/jso.23996
Sun Z, Shenoi MM, Nussbaum DP, Keenan JE, Gulack BC, Tyler DS, Speicher PJ, Blazer
DG 3rd. Feeding jejunostomy tube placement during resection of gastric cancers. J Surg
Res. 2016 Jan;200(1):189-94. doi: 10.1016/j.jss.2015.07.014.
Gulack BC, Englum BR, Lo DD, Nussbaum DP, Keenan JE, Scarborough JE, Shapiro ML.
Leukopenia is associated with worse but not prohibitive outcomes following emergent
abdominal surgery. J Trauma Acute Care Surg. 2015 Sep;79(3):437-43.
Nussbaum DP, Pappas TN, Perez A. Laparoscopic Total Gastrectomy in the Western Pa-
tient Population: Tips, Techniques, and Evidence-based Practice. Surg Laparosc Endosc
Percutan Tech. 2015 Dec;25(6):455-61.
Sun Z, Kim J, Adam MA, Nussbaum DP, Speicher PJ, Mantyh CR, Migaly J. Minimally
Invasive Versus Open Low Anterior Resection: Equivalent Survival in a National Analysis
of 14,033 Patients With Rectal Cancer. Ann Surg. 2016 Jun;263(6):1152-8. doi: 10.1097/
SLA.0000000000001388.
Nussbaum DP, Adam MA, Youngwirth LM, Ganapathi AM, Roman SA, Tyler DS, Sosa JA,
Blazer DG 3rd. Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or
Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarci-
noma. Ann Surg Oncol. 2016 Mar;23(3):1026-33.
Sun Z, Adam MA, Kim J, Nussbaum DP, Benrashid E, Mantyh CR, Migaly J. Determining
the Optimal Timing for Initiation of Adjuvant Chemotherapy After Resection for Stage II
and III Colon Cancer. Dis Colon Rectum. 2016 Feb;59(2):87-93.
Gulack BC, Nussbaum DP, Keenan JE, Ganapathi AM, Sun Z, Worni M, Migaly J, Mantyh
CR. Surgical Resection of the Primary Tumor in Stage IV Colorectal Cancer Without Me-
tastasectomy is Associated With Improved Overall Survival Compared With Chemother-
apy/Radiation Therapy Alone. Dis Colon Rectum. 2016 Apr;59(4):299-305. doi: 10.1097/
DCR.0000000000000546.
Nussbaum DP, Rushing CN, Lane WO, Cardona DM, Kirsch DG, Peterson BL, Blazer DG
Rd. Preoperative or postoperative radiotherapy versus surgery alone for retroperitone-
al sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical
oncology database. Lancet Oncol. 2016 Jul;17(7):966-975.
Lidsky ME, Sun Z, Nussbaum DP, Adam MA, Speicher PJ, Blazer DG 3rd. Going the Extra
Mile: Improved Survival for Pancreatic Cancer Patients Traveling to High-volume Cen-
ters. Ann Surg. 2017 Aug;266(2):333-338.
Anderson GR, Wardell SE, Cakir M, Crawford L, Leeds JC, Nussbaum DP, Shankar PS,
Soderquist RS, Stein EM, Tingley JP, Winter PS, Zieser-Misenheimer EK, Alley HM, Yllanes
A, Haney V, Blackwell KL, McCall SJ, McDonnell DP, Wood KC. PIK3CA mutations enable
targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation. Sci
Transl Med. 2016 Dec 14;8(369):369ra175.
Lidsky ME, Speicher PJ, Ezekian B, Holt EW, Nussbaum DP, Castleberry AW, Perez A,
Pappas TN. Subtotal cholecystectomy for the hostile gallbladder: failure to control the
cystic duct results in significant morbidity. HPB (Oxford). 2017 Jun;19(6):547-556. doi:
10.1016/j.hpb.2017.02.441.
Youngwirth LM, Nussbaum DP, Thomas S, Adam MA, Blazer DG 3rd, Roman SA, Sosa
JA. Nationwide trends and outcomes associated with neoadjuvant therapy in pancre-
atic cancer: An analysis of 18 243 patients. J Surg Oncol. 2017 Aug;116(2):127-132. doi:
10.1002/jso.24630
Warschkow R, Baechtold M, Leung K, Schmied BM, Nussbaum DP, Gloor B, Blazer Iii DG,
Worni M. Selective survival advantage associated with primary tumor resection for met-
astatic gastric cancer in a Western population. Gastric Cancer. 2018 Mar;21(2):324-337.
doi: 10.1007/s10120-017-0742-5.
Anderson GR, Winter PS, Lin KH, Nussbaum DP, Cakir M, Stein EM, Soderquist RS, Craw-
ford L, Leeds JC, Newcomb R, Stepp P, Yip C, Wardell SE, Tingley JP, Ali M, Xu M, Ryan M,
85
Residents
McCall SJ, McRee AJ, Counter CM, Der CJ, Wood KC. A Landscape of Therapeutic Cooper-
ativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution. Cell
Rep. 2017 Jul 25;20(4):999-1015. doi:10.1016/j.celrep.2017.07.006.
Anderson KL Jr, Mulvihill MS, Speicher PJ, Yerokun BA, Gulack BC, Nussbaum DP,
Harpole DH Jr, D’Amico TA, Berry MF, Hartwig MG. Adjuvant Chemotherapy Does Not
Confer Superior Survival in Patients With Atypical Carcinoid Tumors. Ann Thorac Surg.
2017 Oct;104(4):1221-1230. doi:10.1016/j.athoracsur.2017.05.011.
Leung K, Sun Z, Nussbaum DP, Adam MA, Worni M, Blazer DG 3rd. Minimally invasive
gastrectomy for gastric cancer: A national perspective on oncologic outcomes and over-
all survival. Surg Oncol. 2017 Sep;26(3):324-330. doi:10.1016/j.suronc.2017.06.004.
Ong CT, Leung K, Nussbaum DP, Sun Z, Gloor B, Blazer DG 3rd, Worni M. Open
versus laparoscopic portal lymphadenectomy in gallbladder cancer: is there a dif-
ference in lymph node yield? HPB (Oxford). 2018 Jun;20(6):505-513. doi:10.1016/j.
hpb.2017.10.015.
Lazarides AL, Visgauss JD, Nussbaum DP, Green CL, Blazer DG 3rd, Brigman BE, Eward
WC. Race is an independent predictor of survival in patients with soft tissue sarcoma of
the extremities. BMC Cancer. 2018 Apr 27;18(1):488. doi:10.1186/s12885-018-4397-3.
Lane WO, Nussbaum DP, Sun Z, Blazer DG. Preoperative radiation therapy in the surgi-
cal management of gastric and junctional adenocarcinoma: Should lymph node retriev-
al guidelines be altered? J Surg Oncol. 2018 May 25. doi:10.1002/jso.25068.
Köhn N, Maubach J, Warschkow R, Tsai C, Nussbaum DP, Candinas D, Gloor B, Schmied
BM, Blazer DG 3rd, Worni M. High rate of positive lymph nodes in T1a gallbladder
cancer does not translate to decreased survival: a population-based, propensity score
adjusted analysis. HPB (Oxford). 2018 Jun 8. pii:S1365-182X(18)30819-0. doi: 10.1016/j.
hpb.2018.05.007.
LINDA M. YOUNGWIRTH, MD
Education:
M.D., University of Wisconsin School of Medicine, 2012
Training:
General Surgery (PGY1) 6/25/2012-6/30/2013
General Surgery (PGY2) 7/1/2013-6/30/2014
Surgery Research Fellowship – Duke (PGY3) 7/1/2014-6/30/2015
Surgery Research Fellowship – Duke (PGY4) 7/1/2015-6/30/2016
General Surgery (PGY5) 7/1/2016-6/30/2017
General Surgery (PGY6) 7/1/2017-6/30/2018
General Surgery (PGY7) 7/1/2018-Present
Research Interests:
Endocrine Surgery
Clinical Interests:
Minimally invasive and bariatric surgery
Publications:
Youngwirth LM, Benavidez J, Sippel R, Chen H. Parathyroid hormone deficiency after
total thyroidectomy: incidence and time. Journal of Surgical Research. 2010 Sep; 163(1):
69-71.
Youngwirth LM, Benavidez J, Sippel R, Chen H. Postoperative parathyroid hormone test-
ing decreases symptomatic hypocalcemia and associated emergency room visits after
total thyroidectomy. Surgery. 2010 Oct; 148(4): 841-844.
Mazeh H, Benavidez J, Poehls JL, Youngwirth LM, Chen H, Sippel R. In patients with
thyroid cancer of follicular cell origin, a family history in one first-degree relative is
86
Residents
associated with more aggressive disease. Thyroid. 2012 Jan; 22(1); 3-8.
Pinchot SN, Youngwirth LM, Rajamanickam V, Schaefer S, Sippel R, Chen H. Changes in
swallowing-related quality of life after parathyroidectomy for hyperparathyroidism: a
prospective cohort study. Oncologist. 2012; 17(10): 1271-6.
Gilmore B, Benrashid E, Youngwirth LM, Lawson JH. Paradoxical embolus following
percutaneous thrombectomy of hemodialysis reliable outflow graft. Journal of Vascular
Access. 2015 Nov; 16(6): 533-6.
Benrashid E, McCoy CC, Youngwirth LM, Kim J, Manson RJ, Otto JC, Lawson JH. Tissue
engineered vascular grafts: Origins, development, and current strategies for clinical
application. Methods. 2016 Apr; 15(88): 13-9.
Youngwirth LM, Adam MA, Scheri RP, Roman SA, Sosa JA. Patients treated at low volume
centers have higher rates of incomplete resection and compromised outcomes: An
analysis of 31,129 patients with papillary thyroid cancer. Annals of Surgical Oncology.
2016 Feb; 23(2): 403-9.
Adam MA, Youngwirth LM, Scheri RP, Roman SA, Sosa, JA. Same thyroid cancer, differ-
ent national practice guidelines: When discordant ATA and NCCN surgical recommen-
dations are associated with compromised patient outcome. Surgery. 2016 Jan; 159(1):
41-50.
Nussbaum DP, Adam MA, Youngwirth LM, Ganapathi AM, Roman SA, Tyler DS, Sosa JA,
Blazer DG. Minimally invasive pancreaticoduodenectomy does not improve use or time
to initiation of adjuvant chemotherapy in patients with pancreatic adenocarcinoma.
Annals of Surgical Oncology. 2016 Mar; 23(3): 1026-33.
Adam MA, Thomas S, Youngwirth LM, Hyslop T, Reed SD, Scheri RP, Roman SA, Sosa, JA.
Is there a minimum number of thyroidectomies a surgeon should perform to optimize
patient outcomes? Annals of Surgery. 2016 Mar. In press.
Goffredo P, Robinson TJ, Youngwirth LM, Roman SA, Sosa JA. Intensity modulated
radiation therapy use for the localized treatment of thyroid cancer: National practice
patterns and outcomes. Endocrine. 2016 Sep; 53(3): 761-73.
Youngwirth LM, Jillard CL, Scheri RP, Roman SA, Sosa JA. Radioactive iodine treatment
is associated with improved survival for patients with hurthle cell carcinoma. Thyroid.
2016 Jul; 26(7): 959-64.
Anderson KL, Youngwirth LM, Scheri RP, Stang MT, Roman SA, Sosa JA. T1a versus T1b
differentiated thyroid cancers: Do we need to make this distinction? Thyroid. 2016 Aug;
26(8): 1046-52.
Pontius LN, Youngwirth LM, Thomas SM, Scheri RP, Roman SA, Sosa JA. Lymphovascu-
lar invasion is associated with survival for papillary thyroid cancer. Endocrine Related
Cancer. 2016 Jul; 23(7): 555-62.
Youngwirth LM, Adam MA, Scheri RP, Roman SA, Sosa JA. Extrathyroidal extension is
associated with compromised survival in patients with thyroid cancer. Thyroid. 2017
May; 27(5): 626-31.
Benrashid E, Youngwirth LM, Mureebe L, Lawson JH. Operative and perioperative man-
agement of infected arteriovenous grafts. Journal of Vascular Access. 2017 Jan; 18(1):
13-21.
Adam MA, Thomas S, Youngwirth LM, Pappas T, Roman SA, Sosa JA. Defining a hospi-
tal volume threshold for minimally invasive pancreaticoduodenectomy in the United
States. JAMA Surgery. 2017 Apr; 152(4): 336-42.
Adam MA, Thomas S, Youngwirth LM, Hyslop T, Reed SD, Scheri RP, Roman SA, Sosa JA.
Is there a minimum number of thyroidectomies a surgeon should perform to optimize
patient outcomes? Annals of Surgery. 2017 Feb; 265(2): 402-7.
Bendersky V, Sun Z, Adam MA, Rushing C, Kim J, Youngwirth LM, Turner M, Migaly J,
Mantyh CR. Determining the optimal quantitative threshold for preoperative albumin
level before elective colorectal surgery. Journal of Gastrointestinal Surgery. 2017 Apr;
21(4): 692-9.
Youngwirth LM, Nussbaum DP, Thomas S, Adam MA, Blazer DG 3rd, Roman SA, Sosa JA.
87
Residents
88
Residents
Current Residents
PGY-1
Joseph Buchholz, MD
Sidney Kimmel Medical College at Thomas Jefferson University
Doreen Chang, MD
Duke University School of Medicine
Stewart Dalton, MD
University of Florida College of Medicine
Austin Eckhoff, MD
Emory University School of Medicine
89
Residents
Current Residents
PGY-1
Daniel Firl, MD
Case Western Reserve University
Veronica Gross, MD
Rosalind Franklin University of Medicine & Science
Chicago Medical School
Ashley Lau, MD
Harvard Medical School
Harold Leraas, MD
Duke University School of Medicine
90
Residents
PGY-1
Joseph Nellis, MD
University of Iowa Roy J. & Lucille A. Carver College of Medicine
Derek Peters, MD
Harvard Medical School
Stephanie Principe-Marrero, MD
University of North Carolina Chapel Hill School of Medicine
Alvin Rucker, MD
Duke University School of Medicine
91
Residents
Current Residents
PGY-2
Marcelo Cerullo, MD
Johns Hopkins University School of Medicine
Sarah Commander, MD
Baylor College of Medicine
Konstantinos Economopoulos, MD
University of Athens School of Medicine
Samuel Kesseli, MD
Geisel School of Medicine
92
Residents
PGY-2
Dimitrios Moris, MD
University of Athens School of Medicine
Mariya Samoylova, MD
University of California at San Francisco
Brian Shaw, MD
University of California at San Francisco
93
Residents
Current Residents
PGY-3
Morgan Cox, MD
Indiana University School of Medicine
Brian Ezekian, MD
University of Virginia School of Medicine
Michael Mulvihill, MD
Duke University School of Medicine
Uttara Nag, MD
University of Pittsburgh School of Medicine
94
Residents
PGY-3
Cecilia Ong, MD
Duke University School of Medicine
Shanna Sprinkle, MD
Perelman School of Medicine, University of Pennsylvania
Megan Turner, MD
University of Washington School of Medicine
95
Residents
Current Residents
PGY-4
James Meza, MD
University of Michigan Medical School
David Ranney, MD
University of Michigan Medical School
Zhifei Sun, MD
University of Texas Southwestern Medical School
Alice Wang, MD
Duke University School of Medicine
96
Residents
PGY-4
Hanghang Wang, MD
Geisel School of Medicine
Babatunde Yerokun, MD
The Pritzker School of Medicine, University of Chicago
97
Residents
Current Residents
PGY-5
Ehsan Benrashid
University of Virginia School of Medicine
Jina Kim
University of Michigan Medical School
Daniel Nussbaum
University of Southern California, Keck School Of Medicine
98
Residents
PGY-5
Linda Youngwirth
University of Wisconsin School of Medicine
99
Residents
Current Residents
David Becerra, MD
Indiana University School of Medicine
Norma Farrow, MD
Johns Hopkins University School of Medicine
Zachary Fitch, MD
East Virginia Medical School
100
Residents
Brian Gilmore, MD
Duke University School of Medicine
Oliver Jawitz, MD
Yale School of Medicine
Karenia Landa, MD
University of Miami Leonard M. Miller School of Medicine
Whitney Lane, MD
Duke University Medical School
101
Residents
Current Residents
Carrie Moore, MD
Vanderbilt University School of Medicine
Vignesh Raman, MD
Dartmouth Medical School
Christopher Reed, MD
Virginia Tech Carilion School of Medicine
Robin Schmitz, MD
Heidelberg University School of Medicine
102
Residents
Paul Schroder, MD
The University of Toledo College of Medicine
Adam Shoffner, MD
Yale University School of Medicine
David Thompson, MD
Tulane University School of Medicine
103
Residents
Current Residents
Joshua Watson, MD
Johns Hopkins University School of Medicine
John Yerxa, MD
Duke University School of Medicine
104
Residents
105
Residents
The General Surgery Residency Program offers a two-year research experience following the
PGY2 year that is dedicated both to research experiences and learning. The research experiences
are under the guidance of experienced mentors and include clinical and/or basic science research
projects, applications for funding, and meeting abstract and paper submissions. Research topic
and mentor selection officially begins during the PGY1 year and is aided through quarterly
meetings with the Program Director for the research program and the Associate Director for
Research Education. Together the resident and their mentor(s) design a research plan, which is
presented to the Chair of Surgery during the PGY2 year.
Funding for the research years is shared between the Department of Surgery and the mentor’s
division. All PGY2 residents develop and submit a Kirchstein National Research Service Award
(NRSA) proposal for the April deadline prior to their first research year.
The unique interaction between basic science and clinical faculty within the Department of
Surgery, which includes the Division of Surgical Science and other education initiatives (Duke
SCORES and DUKE MERITS), allows the resident to choose from a wide range research topics
that can include cardiovascular, oncology, biomedical engineering, immunology, and transplant
sciences. This interdisciplinary research and clinical education provides an essential
academic experience—applying for a grant from the NIH—and gives fellows the opportunity to
develop a research plan for internal NIH-funded fellowship (institutional T32) grants, the DCRI
Research Fellowship Training Program, or foundation fellowships such as the Thoracic Surgery
Foundation for Research and Education (TSFRE), Ethicon-SUS (Society of University Surgeons),
American College of Surgeons Clinical Scholars in Residence Program, or American Cancer
Society, amongst others.
Progress is monitored by quarterly meetings with the residents and their mentors with the
Research Residency Director and Associate Director for Research Education. Adjustments can
be made along the way, depending on progress and interest. This oversight ensures a rewarding
and successful experience for each resident. Metrics for success include project funding
application submission, meeting abstract submissions and presentations, and paper writing,
submission, and publications.
David H. Harpole, MD
Resident Research Director
Professor of Surgery
Cardiovascular and Thoracic Surgery
106
Research Labs
Research Laboratories
An internationally recognized leader in laboratory and clinical investigation, the Duke Department
of Surgery receives over $60 million dollars of grant and award funding each year. It has been the
top department of surgery recipient of NIH awards for over 20 years.
Our team of over 200 faculty members publish hundreds of articles annually in peer-reviewed
journals, disseminating key findings and insights far beyond our walls. We welcome the
contributions of our residents in advancing the science of surgery in our research labs.
Highlights of research performed at Duke Surgery follow. Find more information at surgery.duke.
edu.
107
Research Labs
Principal Investigator
Randall Scheri, MD
Website
Website
108
Research Labs
Principal Investigator
Carmelo Milano, MD
Website
Principal Investigator
Shu Shiuh-Shi Lin, MD, PhD
Research in the Cardiovascular and Pulmonary Biology Laboratory has investigated various
aspects of chronic aspiration-induced lung injury in non-transplant settings by using a
rodent model of chronic gastric fluid aspiration. Our ongoing studies have revealed that
the development of obliterative bronchiolitis in this model, a major cause of chronic lung
allograft dysfunction (CLAD) in patients, is dependent on a three-hit injury involving: (a)
ischemia-reperfusion injury, (b) alloimmunity, and (c) chronic aspiration. In collaboration
with Dr. William Parker at Duke, we also conduct research into factors present in post-i
dustrial society that lead to aberrant immune function.
Website
109
Research Labs
Prinicipal Investigator
G. Chad Hughes, MD
The goal of the Duke Center for Aortic Disease Research Program is to further our
understanding of the pathophysiology of aortic diseases, develop better surgical and
non-surgical treatments, and improve short- and long-term outcomes after thoracic aortic
surgery. Our key projects include treatment and outcomes of acute and chronic aortic
dissection; improving outcomes after proximal aortic surgery; improving outcomes after
thoracic endovascular aortic repair; and developing and advancing transcatheter aortic
valve replacement.
Website
Principal Investigator
Mani Daneshmand, MD
Website
110
Research Labs
Principal Investigator
Howard Levinson, MD
This laboratory investigates the mechanisms of fibrosis and tissue remodeling and aims to
develop a novel small molecule inhibitor to prevent fibrocontractile disease progression.
There is a large unmet need for an effective pharmaceutical to prevent fibrosis. The main
projects in the laboratory currently seek to: (1) evaluate the clinicopathologic correlation
between expression of NMMII (isoforms IIA, IIB, IIC), myosin light chain kinase (MLCK),
Rho kinase, MRLC, MYPT, and a-SMA as they relate to scar contracture progression and (2)
clarify the relationship between NMMII regulation in fibroblasts, protomyofibroblasts, and
myofibroblasts and tractional force generation.
Website
Principal Investigator
Alexander C. Allori, MD
The DataLab for Clinical Care & Population Health utilizes epidemiology, research-design
principles, biostatistics, and computational data-science methods to focus on the following
areas of research:
Clinically, our predominant focus is on health and health care related to pediatric
conditions, particularly congenital anomalies that require complex, multidisciplinary care.
Website
111
Research Labs
Principal Investigator
Bruce Klitzman, PhD
Researchers in this lab are currently working on the attachment of endothelial cells to
vascu¬lar grafts in order to impart a more blood-compatible surface. We are also studying
methods to implant glucose sensors for diabetics, developing a new generation of
glaucoma drain¬age devices, and improving the biocompatibility of implants through the
coating of a special material that releases nitric oxide. Our projects receive funding from
the National Institutes of Health and the Department of Defense.
Website
Principal Investigator
Linda Cendales, MD
Website
112
Research Labs
Knechtle Lab
Principal Investigator
Stuart Knechtle, MD
Research in the Knechtle Lab focuses on the immunology of organ transplantation. Two
unsolved problems in transplantation are: (1) injury caused by antibody directed at the
donor organ and (2) recurrence of autoimmune disease after transplantation. Neither of
these immu¬nologic injuries is well addressed by current immunosuppressive therapy,
and both prevent successful long-term allograft function. Our laboratory works in animal
models to address the first of these problems and is engaged in human clinical trials to
address the second.
Website
Principal Investigator
Allan D. Kirk, PhD
Our group uses in vitro and animal models to develop transplant strategies and then
investigates them in clinical trials. We also receive samples from patients in clinical trials
to help understand what the next questions should be. We have successfully targeted
several costimulatory molecules with monoclonal antibodies in primates and in humans,
and are currently working to determine the best means of using these molecules to
prevent kidney transplant rejection.
Website
113
Research Labs
Principal Investigator
Jeffrey Lawson, MD, PhD
The Vascular Surgery Research Laboratory is actively pursuing basic, translational, and
clini¬cal research activities related to the fields of blood coagulation, vascular biology, and
vascular surgery. The laboratory has become a leader in the field of vascular translational
research and has successfully developed a number of molecular, cellular, and tissue
engineered technolo¬gies through translational animal studies to first-in-man clinical
trials. Projects include pre¬clinical and clinical evaluation of human tissue engineered
blood vessels; venous remodeling after arterial bypass and vascular access creation; and
human blood coagulation response to trauma and elective surgery.
Website
Principal Investigator
Chin Ho Chen, PhD
Website
114
Research Labs
Principal Investigator
Bruce Sullenger, PhD
Website
Principal Investigator
Gayathri R. Devi, PhD
Website
115
Research Labs
Principal Investigator
H. Kim Lyerly, MD
Website
Principal Investigator
James Koh, PhD
Website
116
Research Labs
Principal Investigators
William Parker, PhD
Website
Principal Investigator
John S. Yi, PhD
117
Research Labs
Principal Investigator
Georgia Tomaras, PhD
Website
Principal Investigator
Kent J. Weinhold, PhD
Website
118
Research Labs
Principal Investigator
Smita Nair, PhD
The research in our laboratory focuses on the design and testing of novel vaccines against
cancer and viral infections using murine and human assay systems. In a pioneering
study, our group demonstrated that dendritic cells, pulsed with unfractionated total RNA
isolated from tumor cells, stimulates tumor immunity both in murine tumor models and
in vitro human assays. A large number of our preclinical strategies have been translated
into Phase I clinical trials in cancer patients. The focus and challenge of our laboratory,
both at the preclinical and clinical level, is to augment the clinical benefit associated
with immunotherapy. Our long-term goals are to: (1) evaluate the combined effects
of individual strategies, (2) extend the clinical exploration to multiple cancers, and (3)
combine immunotherapy and immune modulation with targeted cytotoxic therapy
(radiotherapy, chemotherapy, immunotoxin therapy, and oncolytic poliovirus therapy).
Website
Principal Investigator
Guido Ferrari, MD
Website
119
Research Labs
Principal Investigator
David Montefiori, PhD
Our major research interests are viral immunology and HIV vaccine development, with a
special emphasis on neutralizing antibodies. One of our highest priorities is to identify im-
mu¬nogens that generate broadly neutralizing antibodies for inclusion in vaccines. Many
aspects of neutralizing antibodies are studied in our laboratory, including mechanisms of
neutraliza¬tion, viral escape from neutralization, and epitope diversity among the many
different genetic subtypes and geographic distributions of the virus.
Website
120
Faculty
Faculty
Duke Surgery faculty members are both expert practitioners and valuable mentors. They
have been trained at some of the most prestigious institutions in the country, and many
are regarded internationally as experts in their field. Every year, they perform more than
30,000 procedures, publish hundreds of articles in peer-reviewed journals, and treat some
of the rarest and most challenging medical conditions.
At the same time, they are committed to providing comprehensive training and education
to medical students, residents, and fellows. Faculty members show a high level of respon-
sibility for trainees’ futures, taking the time to develop relationships that support a collab-
orative learning environment. Residents are encouraged to begin mentorship relationships
with faculty in the first year of their training and to develop these into lasting collaborative
associations. This direct access to experts allows residents to gain direct knowledge that
cannot be found through classroom instruction.
In addition to being the academic home for faculty in the traditional general surgical
specialties, the Department houses faculty in Cardiovascular and Thoracic Surgery, Otolar-
yngology, Plastic Surgery, Urologic Surgery, and Vascular Surgery, as well as basic science
faculty within the Division of Surgical Sciences. This enhances the breadth of experience
afforded the general surgery resident. Members of the General Surgery and Cardiovascu-
lar and Thoracic faculty are listed below, as rotations on these specialties are most preva-
lent for the general surgery resident.
121
Faculty
Professor of Surgery
Duke Surgery Profile
Professor of Surgery
Duke Surgery Profile
122
Faculty
Debra L Sudan, MD
Professor of Surgery
Duke Surgery Profile
123
Faculty
124
Faculty
A Daniel Guerron, MD
Assistant Professor of Surgery
Duke Surgery Profile
Kunoor Jain-Spangler, MD
Assistant Professor of Surgery
Duke Surgery Profile
125
Faculty
Ranjan Sudan, MD
Vice Chair of Education
Professor of Surgery
126
Faculty
Professor of Surgery
Professor in Pediatrics
Duke Surgery Profile
127
Faculty
Alexander C Allori, MD
Assistant Professor of Surgery
Duke Surgery Profile
128
Faculty
Gregory S. Georgiade, MD
Vice Chair of Clinical Practice
Professor of Surgery
Duke Surgery Profile
129
Faculty
Howard Levinson, MD
Associate Professor of Surgery
130
Faculty
131
Faculty
132
Faculty
Surgical Oncology
Peter Allen, MD
Chief, Division of Surgical Oncology
133
Faculty
Surgical Oncology
Professor of Surgery
Duke Surgery Profile
134
Faculty
Billy Y Lan, MD
Assistant Professor of Surgery
Duke Surgery Profile
Laura Lazarus, MD
Assistant Professor of Surgery
Duke Surgery Profile
135
Faculty
Surgical Oncology
Professor of Surgery
Duke Surgery Profile
John Migaly, MD
Director, General Surgery Residency Program
136
Faculty
Theodore N. Pappas, MD
The Duke Surgical Innovation Professorship
Professor of Surgery
Duke Surgery Profile
137
Faculty
Surgical Oncology
138
Faculty
139
Faculty
Surgical Oncology
140
Faculty
141
Faculty
Surgical Sciences
142
Faculty
Guido Ferrari, MD
Associate Professor of Surgery
143
Faculty
Surgical Sciences
Li Huang, PhD
Assistant Professor of Surgery
Duke Surgery Profile
144
Faculty
Professor of Surgery
Professor in Immunology
145
Faculty
Surgical Sciences
Professor in Pathology
Duke Surgery Profile
146
Faculty
147
Faculty
Surgical Sciences
Professor in Immunology
He Xu, MD
Assistant Professor of Surgery
Duke Surgery Profile
148
Faculty
149
Faculty
Professor of Surgery
Duke Surgery Profile
150
Faculty
151
Faculty
152
Faculty
Professor in Pathology
Duke Surgery Profile
153
Faculty
Richard L. McCann, MD
Professor of Surgery
Duke Surgery Profile
154
Faculty
155
Faculty
156
Faculty
Professor of Surgery
Duke Surgery Profile
157
Faculty
Professor of Surgery
Matthew Hartwig, MD
Associate Professor of Surgery
Duke Surgery Profile
158
Faculty
Jacob A Klapper, MD
Assistant Professor of Surgery
Duke Surgery Profile
159
Faculty
Professor of Surgery
Duke Surgery Profile
Ryan P Plichta, MD
Assistant Professor of Surgery
Duke Surgery Profile
160
Faculty
Professor of Surgery
Duke Surgery Profile
Joseph W. Turek
Associate Professor of Surgery
Duke Surgery Profile
161
Faculty
162
United, for all patients.